If you have been reading about size-exclusion HPLC and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-03-12. Numbers and descriptions here follow the published literature rather than marketing material.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
Quality control for peptide material focuses on identity, purity, content and the profile of impurities. Common degradants include deamidated and oxidised forms, plus aggregates formed during storage or handling. Forced degradation studies under heat, light, acid and peroxide help define which conditions accelerate change and which analytical methods detect it. Limits for individual impurities are set by pharmacopoeial monographs or manufacturer specifications. How much a given impurity affects biological activity is often uncertain, and conclusions may depend on the assay used.
Solid peptide material is generally kept at reduced temperature to limit degradation. Short-term storage at 2 to 8 degrees Celsius is common, while longer archival storage at minus 20 degrees Celsius or below is typical for lyophilised powder. Vials should remain sealed and protected from light, because ultraviolet exposure can oxidise susceptible residues. Repeated freeze-thaw cycles are avoided, as they promote aggregation and loss of soluble material. Solutions are less stable than solids and are usually prepared close to the time of use.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C187H291N45O59 | free base, without counter-ion |
| Molecular weight | About 4114 Da | peptide backbone plus attached lipid chain |
| Plasma half-life | About 165 hours | supports once-weekly dosing in humans |
| Plasma protein binding | Greater than 99 percent | attributed mainly to serum albumin |
| Receptor target | GLP-1 receptor | Gs-coupled, raises intracellular cyclic AMP |
Reverse-phase high-performance liquid chromatography is the standard method for purity assessment, separating the peptide from truncated or oxidized variants. Mass spectrometry confirms molecular mass and detects modifications, while ultraviolet absorbance near 280 nanometers supports concentration measurement through tryptophan and tyrosine residues. Circular dichroism can indicate secondary structure, though the peptide is largely helical in solution, and ion-exchange chromatography resolves charge variants. Purity values above 95 percent are typical for research-grade material. Stability studies track degradation over time under defined conditions.
Lyophilized semaglutide is typically stored at temperatures between minus 20 and minus 80 degrees Celsius for long-term preservation. Short-term storage at 2 to 8 degrees Celsius is common for working aliquots. Repeated freeze-thaw cycles can degrade the peptide and are usually avoided. The molecule is hygroscopic in its solid form, so containers should remain sealed with desiccant. Solutions are less stable than powders and are generally prepared fresh. Light exposure is limited because aromatic residues can undergo photo-oxidation.
Handling practices center on minimizing contamination and adsorption. Lyophilized peptide tends to accumulate static charge, so weighing is done with antistatic measures and calibrated balances. Reconstitution with appropriate solvent should be gentle, avoiding vigorous vortexing that generates foam and shear. Solutions are typically aliquoted before freezing to reduce repeated temperature cycling. Personal protective equipment and a fume hood are standard for powder handling.
Reconstituted solutions are less stable than the dry powder, and stability depends on concentration, pH, buffer composition, and container material. Low-protein-binding tubes reduce loss of peptide to plastic surfaces. Some researchers add a carrier protein to limit adsorption at low concentrations. The exact shelf life of a given solution is best determined empirically through a stability study rather than assumed from general guidance, because published data cover only a limited set of conditions.
Storage conditions for semaglutide depend heavily on the presentation. Lyophilized research powder is generally kept at two to eight degrees Celsius in a sealed container, protected from light and moisture. Manufacturer labeling for finished injectable products specifies refrigeration before first use, with defined in-use periods at room temperature afterward. The oral tablet form is stored at controlled room temperature and is more tolerant of short excursions. Temperature excursions should be documented rather than inferred.
The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.
Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.
Lyophilised semaglutide is generally held at -20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept at 2-8 °C and used within a defined window because degradation accumulates over time. Repeated freeze-thaw cycles are discouraged, since each cycle can promote aggregation and reduce monomeric content. Room-temperature stability of the solid has been examined in some studies but remains incompletely characterised for long durations, so cold storage is the conservative default for research material.
Degradation proceeds along several parallel routes. Deamidation of asparagine and glutamine residues generates charged variants that shift retention time in chromatographic analysis. Oxidation targets methionine and can be accelerated by trace metals or dissolved oxygen. Non-covalent aggregation produces dimers, oligomers, and larger species that are difficult to reverse. Isomerisation at aspartate residues is slower but measurable under thermal stress. The distribution among these pathways depends on pH, buffer composition, ionic strength, and the presence of excipients such as sugars or surfactants.
Treatment typically takes place in hospital such as in a burn unit or intensive care unit. Efforts may include stopping the cause, pain medication, antihistamines, antibiotics, intravenous immunoglobulins or corticosteroids. Together with TEN, SJS affects 1 to 2 people per million per year. Typical onset is under the age of 30. Skin usually regrows over two to three weeks; however, complete recovery can take months. Overall, the risk of death with SJS is 5 to 10%.
== Chemistry == Pseudoephedrine, also known structurally as (1S,2S)-α,N-dimethyl-β-hydroxyphenethylamine or as (1S,2S)-N-methyl-β-hydroxyamphetamine, is a substituted phenethylamine, amphetamine, and β-hydroxyamphetamine derivative. It is a diastereomer of ephedrine. Pseudoephedrine is a small-molecule compound with the molecular formula C10H15NO and a molecular weight of 165.23 g/mol. It has an experimental log P of 0.89, while its predicted log P values range from 0.9 to 1.32. The compound is relatively lipophilic, but is also more hydrophilic than other amphetamines. The lipophilicity of amphetamines is closely related to their brain permeability. For comparison to pseudoephedrine, the experimental log P of methamphetamine is 2.1, of amphetamine is 1.8, of ephedrine is 1.1, of phenylpropanolamine is 0.7, of phenylephrine is -0.3, and of norepinephrine is -1.2. Methamphetamine has high brain permeability, whereas phenylephrine and norepinephrine are peripherally selective drugs. The optimal log P for brain permeation and central activity is about 2.1 (range 1.5–2.7). Pseudoephedrine is readily reduced into methamphetamine or oxidized into methcathinone.
== Occurrence and production == Polonium is a very rare element in nature because of the short half-lives of all its isotopes. Nine isotopes, from 210 to 218 inclusive, occur in traces as decay products: 210Po, 214Po, and 218Po occur in the decay chain of 238U; 211Po and 215Po occur in the decay chain of 235U; 212Po and 216Po occur in the decay chain of 232Th; and 213Po and 217Po occur in the decay chain of 237Np. (No primordial 237Np survives, but traces of it are continuously regenerated through (n,2n) knockout reactions in natural 238U. The ratio of neptunium to uranium is around 1 to 1012, but having a shorter half-life the ratio in terms of radioactivity is around 1 to 109. 217Po only occurs if 225Ra decays to 221Rn, with a probability of 0.000026, and then the 221Rn decays to 217Po with probability 0.22.) Of these, 210Po is the only isotope with a half-life longer than 3 minutes. Polonium can be found in uranium ores at about 0.1 mg per metric ton (1 part in 1010), which is approximately 0.2% of the abundance of radium. The amounts in the Earth's crust are not harmful. Polonium has been found in tobacco smoke from tobacco leaves grown with phosphate fertilizers. Because it is present in small concentrations, isolation of polonium from natural sources is a tedious process. The largest batch of the element ever extracted, performed in the first half of the 20th century, contained only 40 Ci (1.5 TBq) (9 mg) of polonium-210 and was obtained by processing 37 tonnes of residues from radium production.
== PCT and amphetamines == Excessive overdose on amphetamine or its analogs can induce systemic inflammation; in a case report of amphetamine overdose, without bacterial infection, significant elevations in procalcitonin were observed.
After James Chadwick discovered the neutron in 1932, Irène Curie and Frédéric Joliot irradiated aluminium foil with alpha particles. They found that this results in a short-lived radioactive isotope of phosphorus. They noted that positron emission continued after the neutron emissions ceased. Not only had they discovered a new form of radioactive decay, they had transmuted an element into a hitherto unknown radioactive isotope of another, thereby inducing radioactivity where there had been none before. Radiochemistry was now no longer confined to certain heavy elements, but extended to the entire periodic table. Chadwick noted that being electrically neutral, neutrons could penetrate the atomic nucleus more easily than protons or alpha particles. Enrico Fermi and his colleagues in Rome picked up on this idea, and began irradiating elements with neutrons. The radioactive displacement law of Fajans and Soddy said that beta decay causes isotopes to move one element up on the periodic table, and alpha decay causes them to move two down. When Fermi's group bombarded uranium atoms with neutrons, they found a complex mix of half-lives. Fermi therefore concluded that the new elements with atomic numbers greater than 92 (known as transuranium elements) had been created. Meitner and Hahn had not collaborated for many years, but Meitner was eager to investigate Fermi's results. Hahn, initially, was not, but he changed his mind when Aristid von Grosse suggested that what Fermi had found was an isotope of protactinium.
Sources: en.wikipedia.org
Ligaments are composed of two different tissues: white and yellow. The white fibrous tissues are not stretchy, but are extremely strong so that even if the bone were fractured the tissue would remain in place. The white tissue allows subjective freedom of movement. The yellow elastic tissue can be stretched considerably and return to its original length.
=== Outcomes === Treatment with docetaxel increases survival time in people with certain types of cancer. While some clinical trials show median survival times to be increased by approximately only three months, the range of survival time is large. Many people survive beyond five years with treatment from docetaxel, however it is difficult to attribute these findings directly to treatment with docetaxel. Improved median survival time and response indicates that docetaxel slows metastatic cancer progression and can lead to disease-free survival. Conjunctive treatment of prednisone with docetaxel has been shown to lead to improved survival rate as well as improved quality of life and reduction of pain compared with treatments with mitoxantrone. As well as inhibiting mitosis, the presence of docetaxel has been found to lead to the phosphorylation of the oncoprotein bcl-2, which leads to apoptosis of cancer cells that had previously blocked the apoptotic inducing mechanism, leading to tumour regression. Enhanced effects of radiation therapy when combined with docetaxel has been observed in mice. Docetaxel has also been found to have greater cellular uptake and is retained longer intracellularly than paclitaxel allowing docetaxel treatment to be effective with a smaller dose, leading to fewer and less severe adverse effects.
Hooker Hamersley (1865), heir, lawyer, and poet; former president of the Knickerbocker Club Shipley Jones (1868), banker and clubman William Bayard Cutting (1869), financier, philanthropist, namesake of the Bayard Cutting Arboretum State Park Robert Fulton Cutting (1871), financier George Beach de Forest Jr. (1871), capitalist, bibliophile, and art collector Stuyvesant Fish (1871), president of the Illinois Central Railroad James Montaudevert Waterbury Sr. (1873), industrialist, co-founder of the New York Yacht Club Isaac Newton Seligman (1876), heir to investment bank J. & W. Seligman & Co. T. J. Oakley Rhinelander (1878), heir and real estate developer who owned the Schönburg castle in Germany William Fellowes Morgan Sr. (1880), businessman, philanthropist George Henry Warren II (1880), stockbroker and real estate developer who co-founded the Metropolitan Opera and Real Estate Company Eugene Higgins (1882), heir and philanthropist Lewis Morris Rutherfurd Jr. (1882), socialite and sportsman Marshall Orme Wilson (1882), banker and socialite, son-in-law of William Backhouse Astor Jr. George M. La Monte* (1884), chairman of Prudential Financial 1925–1927 Joseph P. Knapp* (1884), businessman, philanthropist, founder of Ducks Unlimited Temple Bowdoin (1885), former executive of J.P. Morgan & Co. Benjamin Guggenheim* (1887), businessman, son of Meyer Guggenheim and member of the Guggenheim family Richard Thornton Wilson Jr.
The Green Book, formally titled Quantities, Units and Symbols in Physical Chemistry, is a compilation of terms and symbols widely used in the field of physical chemistry. It also includes a table of physical constants, tables listing the properties of elementary particles, chemical elements, and nuclides, and information about conversion factors that are commonly used in physical chemistry. The most recent is the third edition (ISBN 978-0-85404-433-7), originally published by IUPAC in 2007. A second printing of the third edition was released in 2008; this printing made several minor revisions to the 2007 text. A third printing of the third edition was released in 2011. The text of the third printing is identical to that of the second printing.
The BNP test is used as an aid in the diagnosis and assessment of severity of heart failure. A recent meta-analysis concerning effects of BNP testing on clinical outcomes of patients presenting to the emergency department with acute dyspnea revealed that BNP testing led to a decrease in admission rates and decrease in mean length of stay, although neither was statistically significant. Effects on all cause hospital mortality was inconclusive. The BNP test is also used for the risk stratification of patients with acute coronary syndromes.
Sources: en.wikipedia.org
=== Solid microneedles === Solid MNs are the first type of MNs fabricated and are the most commonly used. Hard solid MNs have sharp tips that pierce through and form pores on the stratum corneum. A drug patch will then be applied to the skin for drug to be absorbed slowly and passively through numerous micropores. This type of array is designed as a two part system; the microneedle array is first applied to the skin to create microscopic wells just deep enough to penetrate the outermost layer of skin, and then the drug is applied via transdermal patch. Solid microneedles are already used by dermatologists in collagen induction therapy, a method which uses repeated puncturing of the skin with microneedles to induce the expression and deposition of the proteins collagen and elastin in the skin. Solid MNs help increase the permeability and absorption of drugs.
=== Fibrosis === Fibrosis is the scarring of connective tissue, one attribute is the excess deposition of collagen in the extracellular matrix of tissue. Research has shown that HSPs have a role in fibrotic diseases. HSP47 has been shown to be pro-fibrosis in various fibrotic diseases. During the process of fibrosis, HSP47 is expressed and is involved in the production of collagen. HSP47 could be a potential therapeutic agent for fibrotic disease, a down-regulation of HSP47 leads to decreased fibrotic progression.
Beta decay of fission products of mass 98 and lower, or 100, stops at stable (or very long-lived) isotopes of lower atomic number and does not reach technetium. For greater masses, the technetium isotopes are very short-lived and quickly undergo further beta decay. Therefore, the technetium in spent nuclear fuel is practically all 99Tc. In the presence of fast neutrons a small amount of 98Tc will be produced by (n,2n) "knockout" reactions. If nuclear transmutation of fission-derived technetium, or technetium wastes from medical applications, is desired, fast neutrons are therefore not desirable as the long lived 98Tc increases rather than reducing the longevity of the radioactivity in the material. One gram of 99Tc produces 6.2×108 disintegrations a second (that is, 0.62 GBq/g). Technetium has no primordial isotopes and does not occur in nature in significant quantities, and thus a standard atomic weight cannot be given.
=== Effect of bites on humans === An estimated 7,000 to 8,000 people are bitten by venomous snakes in the United States each year, with about five deaths. The most important factor in survival following a severe envenomation is the time elapsed between the bite and treatment. Most deaths occur between 6 and 48 hours after the bite. If antivenom treatment is given within two hours of the bite, the probability of recovery is greater than 99%. When a bite occurs, the amount of venom injected is under voluntary control by the snake. The amount released depends on a variety of factors, including the condition of the snake (e.g., having long, healthy fangs and a full venom sack) and its temperament (an angry, hungry snake that has just been stepped on vs. a satiated snake that was merely surprised by walking near it). About 20% of bites result in no envenomation at all. A lack of burning pain and edema 1 cm (0.39 in) away from the fang marks after one hour suggests either no or minimal envenomation occurred. A lack of edema or erythema in the area of the bite after eight hours indicates a lack of envenomation for most rattlesnake bites. Common symptoms include swelling, severe pain, tingling, weakness, anxiety, nausea and vomiting, hemorrhaging, perspiration, and (rarely) heart failure. Local pain following envenomation is often intense, increasing with the ensuing edema. Children generally experience more severe symptoms because they receive a larger amount of venom per unit of body mass.
Sources: en.wikipedia.org
Native GLP-1 is a short-lived peptide cleared within one to two minutes by dipeptidyl peptidase-4 and related enzymes. Semaglutide keeps the receptor-binding backbone but adds substitutions and a lipid chain. These changes block the main cleavage site and allow reversible albumin binding, extending the half-life to roughly 165 hours.
Albumin is the most abundant protein in plasma and carries molecules that bear fatty-acid chains. Binding shields the peptide from renal filtration and from peptidases, keeping a circulating reservoir. Slow release from this reservoir produces sustained receptor occupancy and supports infrequent dosing.
The insulinotropic effect is glucose-dependent, meaning secretion increases mainly when glucose is elevated. This property is often described as lowering the chance of hypoglycaemia when the compound is used alone. Other glucose-lowering agents used at the same time can still cause low blood glucose.
Lower temperatures slow hydrolysis, oxidation and aggregation reactions that degrade the molecule over time. Lyophilised powder is more tolerant than solution, but both benefit from controlled conditions.